Production assistance for cellular therapies (pact)- cell processing facilities
Ended Awarded Last action
- Contract number
- HHSN268201600015I
- Awardee
-
Baylor College Of Medicine UEI FXKMA43NTV21
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 5 $2,021,177 obligated
Award facts
- Opportunity
-
- NHLBIECBHB201609JB Solicitation number
- Combined order value
- $2,021,177 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 4% used
- $45,630,651.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- 10 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The National Heart, Lung, and Blood Institute awarded a multiple-award indefinite-delivery contract to Baylor College of Medicine on August 1, 2016, with a ceiling of $45.63 million and ultimate completion date of June 30, 2022, to procure cell manufacturing, process development, and administrative support services for cellular therapy production facilities under the Production Assistance for Cellular Therapies (PACT) program.
Place of performance is Houston, Texas. The IDIQ funds cell processing facilities and associated technical assistance to advance cellular therapy manufacturing capabilities in support of the National Institutes of Health's regenerative medicine and clinical translation objectives.
Baylor College of Medicine, a private nonprofit research-intensive academic health sciences institution, competes full-and-open and holds no socioeconomic set-asides. Four delivery orders issued under this IDIQ are documented in the source. The largest is a cost-no-fee delivery order valued at $1.14 million awarded January 31, 2020, covering cell manufacturing and process development services for clinical production of viral-specific T cell lines under PCT0027-01, with performance through March 2022. Three additional cost-no-fee delivery orders totaling approximately $303 thousand were awarded between August 2017 and December 2018 for cryopreservation technical studies and T cell transduction strategy development. A firm fixed price delivery order valued at $576.18 thousand, designated Task Area #1, provides administrative and regulatory program support services, with performance extending through June 2021.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN268201600015I?
HHSN268201600015I was awarded to Baylor College Of Medicine by National Heart Lung and Blood Institute (National Institutes of Health) on August 1, 2016.
How much is contract HHSN268201600015I worth?
Orders under HHSN268201600015I have obligated $2,021,177. HHSN268201600015I's own ceiling is $45,630,651.
How many orders have been placed under contract HHSN268201600015I?
5 orders have been placed under HHSN268201600015I, the latest on January 31, 2020.
Who can order from contract HHSN268201600015I?
HHSN268201600015I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN268201600015I part of a contract vehicle?
Yes. HHSN268201600015I is part of Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF).
Was contract HHSN268201600015I competed?
The government received 10 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV